Walgreens ready to embrace 'Cost Plus' drug model, CEO says

Walgreens’ new CEO Tim Wentworth says the pressure is on to develop new drug pricing models following a recent shift in the retail pharmacy market “to give patients the Cost Plus experience.”

Read the full post on Becker's Hospital Review - Healthcare News